RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication Gallery RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication All News, Portfolio News RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indicationartrix2023-07-06T23:39:04-07:00July 4th, 2023|Read More
ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchange Gallery ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchange All News, Portfolio News ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchangeartrix2022-11-09T23:02:31-08:00November 9th, 2022|Read More
Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics Gallery Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics All News, Portfolio News Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeuticsartrix2022-11-09T22:59:01-08:00November 7th, 2022|Read More
NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma Gallery NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma All News, Portfolio News NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthmaartrix2022-09-30T02:06:18-07:00September 16th, 2022|Read More
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Gallery FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older All News, Portfolio News FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Olderartrix2022-08-03T22:23:46-07:00August 1st, 2022|Read More
Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China Gallery Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China All News, Portfolio News Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater Chinaartrix2022-04-26T22:09:31-07:00April 25th, 2022|Read More
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn Gallery GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn All News, Portfolio News GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnartrix2022-04-20T22:44:40-07:00April 13th, 2022|Read More
Legend Biotech Announces FDA Approval of CARVYKTI Gallery Legend Biotech Announces FDA Approval of CARVYKTI All News, Portfolio News Legend Biotech Announces FDA Approval of CARVYKTIartrix2022-03-09T22:31:31-08:00February 28th, 2022|Read More
Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering Gallery Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering All News, Portfolio News Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offeringartrix2022-03-09T22:35:05-08:00February 22nd, 2022|Read More
Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital Gallery Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital All News, Portfolio News Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capitalartrix2022-03-09T22:05:12-08:00December 8th, 2021|Read More
Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market Gallery Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market All News, Portfolio News Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market artrix2022-03-09T21:58:39-08:00November 30th, 2021|Read More
Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) All News, Portfolio News Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)artrix2022-03-09T21:51:12-08:00November 23rd, 2021|Read More
IO Biotech, Inc. Announces Pricing of Initial Public Offering Gallery IO Biotech, Inc. Announces Pricing of Initial Public Offering All News, Portfolio News IO Biotech, Inc. Announces Pricing of Initial Public Offeringartrix2022-03-09T21:47:53-08:00November 5th, 2021|Read More
PatientPop and Kareo Merge to Create All-In-One Provider Platform Gallery PatientPop and Kareo Merge to Create All-In-One Provider Platform All News, Portfolio News PatientPop and Kareo Merge to Create All-In-One Provider Platformartrix2022-03-09T21:46:32-08:00November 2nd, 2021|Read More
Minerva Surgical Announces Pricing of Initial Public Offering Gallery Minerva Surgical Announces Pricing of Initial Public Offering All News, Portfolio News Minerva Surgical Announces Pricing of Initial Public Offeringartrix2022-03-09T20:28:46-08:00October 21st, 2021|Read More
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Gallery Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering All News, Portfolio News Ventyx Biosciences Announces Pricing of Upsized Initial Public Offeringartrix2022-03-09T20:26:43-08:00October 20th, 2021|Read More
HistoWiz Raises $32M Series A Financing Gallery HistoWiz Raises $32M Series A Financing All News, Portfolio News HistoWiz Raises $32M Series A Financingartrix2022-03-09T20:19:19-08:00October 19th, 2021|Read More
Neurogastrx Secures $60M in Series B Financing Gallery Neurogastrx Secures $60M in Series B Financing All News, Vivo News Neurogastrx Secures $60M in Series B Financingartrix2022-03-09T20:17:13-08:00August 26th, 2021|Read More
Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency Gallery Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency All News, Portfolio News Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiencyartrix2022-03-09T20:15:49-08:00August 25th, 2021|Read More
Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® Gallery Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® All News, Portfolio News Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK®artrix2022-03-09T20:14:24-08:00July 16th, 2021|Read More
Sera Prognostics Announces Pricing of Initial Public Offering Gallery Sera Prognostics Announces Pricing of Initial Public Offering All News, Portfolio News Sera Prognostics Announces Pricing of Initial Public Offeringartrix2022-03-09T20:12:23-08:00July 14th, 2021|Read More
Sinovac is Granted Emergency Use by the World Health Organization (WHO) Gallery Sinovac is Granted Emergency Use by the World Health Organization (WHO) All News, Portfolio News Sinovac is Granted Emergency Use by the World Health Organization (WHO)artrix2022-03-09T20:11:05-08:00June 1st, 2021|Read More
Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment Gallery Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment All News, Portfolio News Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatmentartrix2022-03-09T20:09:37-08:00May 28th, 2021|Read More
Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital Gallery Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital All News, Portfolio News Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capitalartrix2022-03-09T20:08:04-08:00May 26th, 2021|Read More
Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing Gallery Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing All News, Portfolio News Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financingartrix2022-03-09T20:06:36-08:00May 25th, 2021|Read More
Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement Gallery Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement All News, Portfolio News Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreementartrix2022-03-09T20:04:25-08:00May 17th, 2021|Read More
Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital Gallery Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital All News, Portfolio News Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capitalartrix2022-03-09T20:02:47-08:00May 6th, 2021|Read More
dMed Globaland Clinipace Merge to Accelerate Customer Success Gallery dMed Globaland Clinipace Merge to Accelerate Customer Success All News, Portfolio News dMed Globaland Clinipace Merge to Accelerate Customer Successartrix2022-03-09T22:28:22-08:00April 28th, 2021|Read More
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering Gallery Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering All News, Portfolio News Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offeringartrix2022-03-09T22:19:53-08:00April 22nd, 2021|Read More
Instil Bio Announces Pricing of Upsized Initial Public Offering Gallery Instil Bio Announces Pricing of Upsized Initial Public Offering All News, Portfolio News Instil Bio Announces Pricing of Upsized Initial Public Offeringartrix2022-03-09T22:17:53-08:00March 18th, 2021|Read More
Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work Gallery Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work All News, Portfolio News Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer workartrix2021-02-08T23:06:15-08:00February 5th, 2021|Read More
Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock Gallery Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock All News, Portfolio News Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stockartrix2022-03-09T22:14:54-08:00February 4th, 2021|Read More
Surgical Specialties is Acquired by Corza Health Gallery Surgical Specialties is Acquired by Corza Health All News, Portfolio News Surgical Specialties is Acquired by Corza Healthartrix2022-03-09T19:57:13-08:00February 1st, 2021|Read More
Preventice is Acquired by Boston Scientific Gallery Preventice is Acquired by Boston Scientific All News, Vivo News Preventice is Acquired by Boston Scientificartrix2022-03-09T19:55:54-08:00January 21st, 2021|Read More
Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry. Gallery Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry. All News, Portfolio News Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry.artrix2022-03-10T22:19:26-08:00January 15th, 2021|Read More
Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China Gallery Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China All News, Portfolio News Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater Chinaartrix2022-03-09T19:50:01-08:00January 11th, 2021|Read More
Vivo Capital Appoints New Managing Partners and Partners Gallery Vivo Capital Appoints New Managing Partners and Partners All News, Vivo News Vivo Capital Appoints New Managing Partners and Partnersartrix2021-01-11T09:41:11-08:00January 11th, 2021|Read More
Gracell Biotechnologies Announces Pricing of Initial Public Offering Gallery Gracell Biotechnologies Announces Pricing of Initial Public Offering All News, Portfolio News Gracell Biotechnologies Announces Pricing of Initial Public Offeringartrix2022-03-09T22:12:14-08:00January 8th, 2021|Read More
Serán Bioscience Announces Investment by Vivo Capital Gallery Serán Bioscience Announces Investment by Vivo Capital All News, Vivo News Serán Bioscience Announces Investment by Vivo Capitalartrix2022-03-09T19:44:04-08:00January 6th, 2021|Read More
Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription Gallery Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription All News, Portfolio News Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscriptionartrix2020-11-01T16:37:55-08:00September 17th, 2020|Read More
PatientPop Announces $50M in Series C Funding Gallery PatientPop Announces $50M in Series C Funding All News, Portfolio News PatientPop Announces $50M in Series C Fundingartrix2020-11-01T16:34:46-08:00August 25th, 2020|Read More
ALX Oncology Announces Pricing of Initial Public Offering Gallery ALX Oncology Announces Pricing of Initial Public Offering All News, Portfolio News ALX Oncology Announces Pricing of Initial Public Offeringartrix2020-07-25T10:49:23-07:00July 16th, 2020|Read More
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Gallery Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital All News, Portfolio News Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capitalartrix2020-07-16T22:33:36-07:00July 15th, 2020|Read More
Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D Gallery Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D All News, Vivo News Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&Dartrix2020-07-09T11:12:39-07:00July 9th, 2020|Read More
Genetron Health Announces Pricing of Initial Public Offering Gallery Genetron Health Announces Pricing of Initial Public Offering All News, Portfolio News Genetron Health Announces Pricing of Initial Public Offeringartrix2020-06-20T10:42:44-07:00June 19th, 2020|Read More
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Gallery IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants All News, Portfolio News IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrantsartrix2020-06-20T10:44:04-07:00June 18th, 2020|Read More
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Gallery Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 All News, Portfolio News Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19artrix2022-03-23T21:35:37-07:00June 13th, 2020|Read More
Legend Biotech Corporation Announces Pricing of Public Offering Gallery Legend Biotech Corporation Announces Pricing of Public Offering All News, Portfolio News Legend Biotech Corporation Announces Pricing of Public Offeringartrix2022-03-09T22:23:03-08:00June 5th, 2020|Read More
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform Gallery Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform All News, Portfolio News, Vivo News Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platformartrix2020-04-21T13:06:00-07:00April 21st, 2020|Read More
RemeGen Completes USD $100 Million Plus in Funding Gallery RemeGen Completes USD $100 Million Plus in Funding All News, Portfolio News RemeGen Completes USD $100 Million Plus in Fundingartrix2020-04-21T13:04:42-07:00April 2nd, 2020|Read More
Gilead to Acquire Forty Seven for $4.9 Billion Gallery Gilead to Acquire Forty Seven for $4.9 Billion All News, Portfolio News Gilead to Acquire Forty Seven for $4.9 Billionartrix2020-06-18T17:04:46-07:00March 2nd, 2020|Read More
Passage Bio Announces Pricing of Initial Public Offering Gallery Passage Bio Announces Pricing of Initial Public Offering All News, Portfolio News Passage Bio Announces Pricing of Initial Public Offeringartrix2020-06-18T17:01:08-07:00February 27th, 2020|Read More
Revolution Medicines Announces Pricing of Initial Public Offering Gallery Revolution Medicines Announces Pricing of Initial Public Offering All News, Portfolio News Revolution Medicines Announces Pricing of Initial Public Offeringartrix2020-06-18T17:03:04-07:00February 12th, 2020|Read More
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Gallery Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors All News, Portfolio News Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumorsartrix2019-11-13T04:26:51-08:00November 11th, 2019|Read More
Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants Gallery Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants All News, Portfolio News Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrantsartrix2020-06-20T10:45:51-07:00November 7th, 2019|Read More
Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies Gallery Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies All News, Vivo News Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companiesartrix2019-10-30T13:46:20-07:00October 30th, 2019|Read More
Swift Health Systems Raises $45 Million in Series C Funding Gallery Swift Health Systems Raises $45 Million in Series C Funding All News, Vivo News Swift Health Systems Raises $45 Million in Series C Fundingartrix2020-01-22T00:27:56-08:00October 8th, 2019|Read More
IGM Biosciences Announces Pricing of Initial Public Offering Gallery IGM Biosciences Announces Pricing of Initial Public Offering All News, Portfolio News IGM Biosciences Announces Pricing of Initial Public Offeringartrix2020-06-18T16:58:47-07:00September 17th, 2019|Read More
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART Gallery AtriCure Enters Into Definitive Agreement to Acquire SentreHEART All News, Portfolio News AtriCure Enters Into Definitive Agreement to Acquire SentreHEARTartrix2019-10-19T05:30:49-07:00August 12th, 2019|Read More
Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare Gallery Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare All News, Portfolio News, Vivo News Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcareartrix2020-01-22T00:29:14-08:00July 30th, 2019|Read More
MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital Gallery MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital All News, Portfolio News MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capitalartrix2020-11-01T16:31:29-08:00March 4th, 2019|Read More
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis Gallery Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis All News, Portfolio News Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasisartrix2019-10-19T05:31:06-07:00December 10th, 2018|Read More
Impel NeuroPharma Closes $67.5 Million Series D Financing Gallery Impel NeuroPharma Closes $67.5 Million Series D Financing All News, Portfolio News, Vivo News Impel NeuroPharma Closes $67.5 Million Series D Financingartrix2019-10-19T05:34:48-07:00December 6th, 2018|Read More
Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine Gallery Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine All News, Portfolio News Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraineartrix2019-10-19T05:31:30-07:00December 3rd, 2018|Read More
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China Gallery Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China All News, Portfolio News, Vivo News Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in Chinaartrix2019-10-19T05:35:03-07:00November 8th, 2018|Read More
Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer Gallery Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer All News, Portfolio News, Vivo News Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancerartrix2019-10-19T05:35:16-07:00October 30th, 2018|Read More
Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities Gallery Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities All News, Vivo News Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equitiesartrix2019-10-19T05:31:53-07:00September 11th, 2018|Read More
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering Gallery Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering All News, Portfolio News Crinetics Pharmaceuticals Announces Pricing of Initial Public Offeringartrix2019-10-19T05:32:01-07:00July 17th, 2018|Read More
Sinovac Raises $86.73 Million Through Private Placement Transaction Gallery Sinovac Raises $86.73 Million Through Private Placement Transaction All News, Portfolio News, Vivo News Sinovac Raises $86.73 Million Through Private Placement Transactionartrix2019-10-19T05:35:28-07:00July 3rd, 2018|Read More
Tricida Announces Pricing of Initial Public Offering Gallery Tricida Announces Pricing of Initial Public Offering All News, Portfolio News Tricida Announces Pricing of Initial Public Offeringartrix2019-10-19T05:32:18-07:00June 27th, 2018|Read More
Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million Gallery Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million All News, Vivo News Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Millionartrix2019-10-19T05:32:32-07:00June 13th, 2016|Read More
Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China Gallery Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China All News, Vivo News Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater Chinaartrix2019-10-19T05:32:39-07:00March 17th, 2015|Read More
Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China Gallery Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China All News, Vivo News Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater Chinaartrix2019-10-19T05:32:47-07:00January 3rd, 2012|Read More